BNP Paribas Asset Management’s Organon & Co OGN Stock Holding History

BNP Paribas Asset Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.6K	Sell	4,032 -332,944	-99%	-$3.98M	﹤0.01%	1737
2026 Q1	$2.02M	Buy	336,976 +1,340	+0.4%	+$10.1K	﹤0.01%	1073
2025 Q4	$2.41M	Buy	335,636 +332,742	+11,498%	+$2.63M	﹤0.01%	1035
2025 Q3	$31K	Hold	2,894	–	–	﹤0.01%	1228
2025 Q2	$28K	Buy	+2,894	New	+$29.8K	﹤0.01%	1368
2022 Q1	–	Sell	-11,763	Closed	-$358K	–	922
2021 Q4	$358K	Buy	11,763 +3,204	+37%	+$104K	﹤0.01%	852
2021 Q3	$281K	Sell	8,559 -3,792	-31%	-$121K	﹤0.01%	842
2021 Q2	$374K	Buy	+12,351	New	+$407K	﹤0.01%	838

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

BNP Paribas Asset Management's OGN Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Organon & Co (OGN) stake by 99% in Q2 2026, selling an estimated $3.98M and leaving 4,032 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1737.

BNP Paribas Asset Management first reported a position in OGN in Q2 2021 and has held it in 8 quarters since. The position peaked at $2.41M in Q4 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

BNP Paribas Asset Management held 4,032 shares of Organon & Co worth $54.6K as of Q2 2026.
BNP Paribas Asset Management sold 332,944 Organon & Co shares in Q2 2026, an estimated $3.98M.
Organon & Co made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1737 holding.
BNP Paribas Asset Management first reported a position in Organon & Co in Q2 2021 and has held it in 8 quarters since.
BNP Paribas Asset Management's Organon & Co position peaked at $2.41M in Q4 2025.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.